These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 21663387)

  • 1. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
    Cruzado JM; Poveda R; Ibernón M; Díaz M; Fulladosa X; Carrera M; Torras J; Bestard O; Navarro I; Ballarín J; Romero R; Grinyó JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3596-602. PubMed ID: 21393611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O; Watier L; Rossert J; Stengel B;
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
    Courtney AE; McNamee PT; Nelson WE; Maxwell AP
    Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
    J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of acute renal failure in IgA nephropathy.
    Wen YK; Chen ML
    Ren Fail; 2010 May; 32(4):428-33. PubMed ID: 20446779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
    Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
    Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Amemiya N; Ochi A; Tsuruta Y; Shimizu A; Itabashi M; Takei T; Uchida K; Nitta K
    Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK; Leung CB; Chow KM; Cheng YL; Fung SK; Mak SK; Tang AW; Wong TY; Yung CY; Yung JC; Yu AW; Szeto CC;
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.